CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI

Translated title of the contribution: Control of intimal hyperplasia in small diameter PTFE grafts. Preliminary results

G. Simoni, R. Galleano, P. Ceppa, P. Desalvo, P. Cariati, P. Baccini, E. Lenti, A. Baiardi, D. Civalleri

Research output: Contribution to journalArticle

Abstract

Intimal hyperplasia is one of the main risk factors for the patency of small diameter bypass grafts. The standard unfractioned heparin (UH) is able to control this phenomenon but the clinical use is not fit for long term treatment; on the other hand the antiplatelet drugs have an anti-thrombotic effect but they seem to be unable to control intimal hyperplasia. Low molecular weight heparins (LMWH) have an anti-thrombotic effect superimposable to that of UH with minimal side-effects and might inhibit intimal hyperplasia too. Based on these criteria, we carried out an experimental study on sheep with the aim of evaluating the efficacy of postoperative treatment with LMWH versus an anti-platelet drug in controlling intimal hyperplasia and growth of true endothelial cells in small prosthetic ePTFE grafts (4 mm) interposed in the carotid artery. At the operation, 30 sheep were randomly located in 3 groups: A = control group, no treatment; B = Ticlopidine hydrochloride 250 mg/bid by mouth for 4 weeks; C = LMWH 3.075 IU AXa (0.3 ml) sc preoperatively and then once a day for the same period. Complete thrombosis of the graft occurred in 7 sheep of group A, 5 in B and 2 partial in group C. The intimal hyperplasia was moderate-severe in group A, mild-moderate in group B and no-mild in group C. True endothelial cells were found mainly in the LMWH group; in the other groups and in other portions of the grafts the cellular coverage was accomplished almost completely by fibroblasts. The study is still in progress with 6 further sheep treated with LMWH.

Original languageItalian
Pages (from-to)205-209
Number of pages5
JournalMinerva Cardioangiologica
Volume43
Issue number5
Publication statusPublished - 1995

Fingerprint

Tunica Intima
Low Molecular Weight Heparin
Polytetrafluoroethylene
Hyperplasia
Sheep
Transplants
Heparin
Endothelial Cells
Ticlopidine
Platelet Aggregation Inhibitors
Carotid Arteries
Mouth
Thrombosis
Blood Platelets
Fibroblasts
Control Groups
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Simoni, G., Galleano, R., Ceppa, P., Desalvo, P., Cariati, P., Baccini, P., ... Civalleri, D. (1995). CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI. Minerva Cardioangiologica, 43(5), 205-209.

CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI. / Simoni, G.; Galleano, R.; Ceppa, P.; Desalvo, P.; Cariati, P.; Baccini, P.; Lenti, E.; Baiardi, A.; Civalleri, D.

In: Minerva Cardioangiologica, Vol. 43, No. 5, 1995, p. 205-209.

Research output: Contribution to journalArticle

Simoni, G, Galleano, R, Ceppa, P, Desalvo, P, Cariati, P, Baccini, P, Lenti, E, Baiardi, A & Civalleri, D 1995, 'CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI', Minerva Cardioangiologica, vol. 43, no. 5, pp. 205-209.
Simoni G, Galleano R, Ceppa P, Desalvo P, Cariati P, Baccini P et al. CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI. Minerva Cardioangiologica. 1995;43(5):205-209.
Simoni, G. ; Galleano, R. ; Ceppa, P. ; Desalvo, P. ; Cariati, P. ; Baccini, P. ; Lenti, E. ; Baiardi, A. ; Civalleri, D. / CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI. In: Minerva Cardioangiologica. 1995 ; Vol. 43, No. 5. pp. 205-209.
@article{a52e3877361846cca81c4482ad007335,
title = "CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI",
abstract = "Intimal hyperplasia is one of the main risk factors for the patency of small diameter bypass grafts. The standard unfractioned heparin (UH) is able to control this phenomenon but the clinical use is not fit for long term treatment; on the other hand the antiplatelet drugs have an anti-thrombotic effect but they seem to be unable to control intimal hyperplasia. Low molecular weight heparins (LMWH) have an anti-thrombotic effect superimposable to that of UH with minimal side-effects and might inhibit intimal hyperplasia too. Based on these criteria, we carried out an experimental study on sheep with the aim of evaluating the efficacy of postoperative treatment with LMWH versus an anti-platelet drug in controlling intimal hyperplasia and growth of true endothelial cells in small prosthetic ePTFE grafts (4 mm) interposed in the carotid artery. At the operation, 30 sheep were randomly located in 3 groups: A = control group, no treatment; B = Ticlopidine hydrochloride 250 mg/bid by mouth for 4 weeks; C = LMWH 3.075 IU AXa (0.3 ml) sc preoperatively and then once a day for the same period. Complete thrombosis of the graft occurred in 7 sheep of group A, 5 in B and 2 partial in group C. The intimal hyperplasia was moderate-severe in group A, mild-moderate in group B and no-mild in group C. True endothelial cells were found mainly in the LMWH group; in the other groups and in other portions of the grafts the cellular coverage was accomplished almost completely by fibroblasts. The study is still in progress with 6 further sheep treated with LMWH.",
keywords = "antiplatelet drug, intimal hyperplasia, low molecular weight heparin, vascular graft",
author = "G. Simoni and R. Galleano and P. Ceppa and P. Desalvo and P. Cariati and P. Baccini and E. Lenti and A. Baiardi and D. Civalleri",
year = "1995",
language = "Italian",
volume = "43",
pages = "205--209",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "5",

}

TY - JOUR

T1 - CONTROLLO DELL'IPERPLASIA INTIMALE IN PROTESI DI PICCOLO CALIBRO. RISULTATI PRELIMINARI

AU - Simoni, G.

AU - Galleano, R.

AU - Ceppa, P.

AU - Desalvo, P.

AU - Cariati, P.

AU - Baccini, P.

AU - Lenti, E.

AU - Baiardi, A.

AU - Civalleri, D.

PY - 1995

Y1 - 1995

N2 - Intimal hyperplasia is one of the main risk factors for the patency of small diameter bypass grafts. The standard unfractioned heparin (UH) is able to control this phenomenon but the clinical use is not fit for long term treatment; on the other hand the antiplatelet drugs have an anti-thrombotic effect but they seem to be unable to control intimal hyperplasia. Low molecular weight heparins (LMWH) have an anti-thrombotic effect superimposable to that of UH with minimal side-effects and might inhibit intimal hyperplasia too. Based on these criteria, we carried out an experimental study on sheep with the aim of evaluating the efficacy of postoperative treatment with LMWH versus an anti-platelet drug in controlling intimal hyperplasia and growth of true endothelial cells in small prosthetic ePTFE grafts (4 mm) interposed in the carotid artery. At the operation, 30 sheep were randomly located in 3 groups: A = control group, no treatment; B = Ticlopidine hydrochloride 250 mg/bid by mouth for 4 weeks; C = LMWH 3.075 IU AXa (0.3 ml) sc preoperatively and then once a day for the same period. Complete thrombosis of the graft occurred in 7 sheep of group A, 5 in B and 2 partial in group C. The intimal hyperplasia was moderate-severe in group A, mild-moderate in group B and no-mild in group C. True endothelial cells were found mainly in the LMWH group; in the other groups and in other portions of the grafts the cellular coverage was accomplished almost completely by fibroblasts. The study is still in progress with 6 further sheep treated with LMWH.

AB - Intimal hyperplasia is one of the main risk factors for the patency of small diameter bypass grafts. The standard unfractioned heparin (UH) is able to control this phenomenon but the clinical use is not fit for long term treatment; on the other hand the antiplatelet drugs have an anti-thrombotic effect but they seem to be unable to control intimal hyperplasia. Low molecular weight heparins (LMWH) have an anti-thrombotic effect superimposable to that of UH with minimal side-effects and might inhibit intimal hyperplasia too. Based on these criteria, we carried out an experimental study on sheep with the aim of evaluating the efficacy of postoperative treatment with LMWH versus an anti-platelet drug in controlling intimal hyperplasia and growth of true endothelial cells in small prosthetic ePTFE grafts (4 mm) interposed in the carotid artery. At the operation, 30 sheep were randomly located in 3 groups: A = control group, no treatment; B = Ticlopidine hydrochloride 250 mg/bid by mouth for 4 weeks; C = LMWH 3.075 IU AXa (0.3 ml) sc preoperatively and then once a day for the same period. Complete thrombosis of the graft occurred in 7 sheep of group A, 5 in B and 2 partial in group C. The intimal hyperplasia was moderate-severe in group A, mild-moderate in group B and no-mild in group C. True endothelial cells were found mainly in the LMWH group; in the other groups and in other portions of the grafts the cellular coverage was accomplished almost completely by fibroblasts. The study is still in progress with 6 further sheep treated with LMWH.

KW - antiplatelet drug

KW - intimal hyperplasia

KW - low molecular weight heparin

KW - vascular graft

UR - http://www.scopus.com/inward/record.url?scp=0029112671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029112671&partnerID=8YFLogxK

M3 - Articolo

C2 - 7478044

AN - SCOPUS:0029112671

VL - 43

SP - 205

EP - 209

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

IS - 5

ER -